Literature DB >> 10950817

Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells.

D Rivenzon-Segal1, E Rushkin, S Polak-Charcon, H Degani.   

Abstract

The rates of glucose transport and of glycolysis and the expression of the glucose transporters GLUT-1 through GLUT-4 were measured in T47D human breast cancer cells that underwent differentiation by retinoic acid. Glucose transport was found to be the rate-limiting step of glycolysis in control and differentiated cells. The transporters GLUT-1, GLUT-3, and GLUT-4 were present in the cell membrane and in the cytoplasm, and GLUT-2 was present solely in the cytoplasm. Differentiation led to a reduction in GLUT-1 and to an increase in cytoplasmic GLUT-2 and GLUT-3 with no change in GLUT-4. Differentiation also caused a reduction in the maximal velocity of glucose transport by approximately 40% without affecting the Michaelis-Menten constant of glucose transport. These changes did not alter the steady-state concentration of the phosphate metabolites regulating cell energetics but increased the content of phospholipid breakdown phosphodiesters. In conclusion, differentiation of human breast cancer cells appears to be associated with decreased glycolysis by a mechanism that involves a reduction in GLUT-1 and a slowdown of glucose transport.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950817     DOI: 10.1152/ajpendo.2000.279.3.E508

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  13 in total

1.  Prognostic significance of the standardized uptake value of pre-therapeutic (18)F-FDG PET in patients with malignant lymphoma.

Authors:  Hossein Ahmadzadehfar; Margarida Rodrigues; Rasoul Zakavi; Peter Knoll; Siroos Mirzaei
Journal:  Med Oncol       Date:  2010-06-04       Impact factor: 3.064

2.  Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis.

Authors:  M A Kocdor; H Kocdor; J S Pereira; J E Vanegas; I H Russo; J Russo
Journal:  Clin Transl Oncol       Date:  2012-10-02       Impact factor: 3.405

3.  Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer.

Authors:  Kannie W Y Chan; Michael T McMahon; Yoshinori Kato; Guanshu Liu; Jeff W M Bulte; Zaver M Bhujwalla; Dmitri Artemov; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2012-10-16       Impact factor: 4.668

4.  Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells.

Authors:  Yong Yang; Joy Wolfram; Kathryn Boom; Xiaohong Fang; Haifa Shen; Mauro Ferrari
Journal:  Cell Biochem Funct       Date:  2012-10-08       Impact factor: 3.685

5.  Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells.

Authors:  Talia Harris; Galit Eliyahu; Lucio Frydman; Hadassa Degani
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-13       Impact factor: 11.205

Review 6.  Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.

Authors:  Jin-Qiang Chen; Terry R Brown; Jose Russo
Journal:  Biochim Biophys Acta       Date:  2009-04-05

7.  Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells.

Authors:  Varun Khurana; Deep Kwatra; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2014-08-04       Impact factor: 5.875

8.  The power of FDG-PET to detect treatment effects is increased by glucose correction using a Michaelis constant.

Authors:  Simon-Peter Williams; Judith E Flores-Mercado; Andreas R Baudy; Ruediger E Port; Thomas Bengtsson
Journal:  EJNMMI Res       Date:  2012-06-27       Impact factor: 3.138

9.  Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transport.

Authors:  Simon-Peter Williams; Judith E Flores-Mercado; Ruediger E Port; Thomas Bengtsson
Journal:  EJNMMI Res       Date:  2012-02-01       Impact factor: 3.138

10.  Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death.

Authors:  R L Aft; F W Zhang; D Gius
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.